R
Ritu Banerjee
Researcher at Vanderbilt University
Publications - 76
Citations - 2228
Ritu Banerjee is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 62 publications receiving 1814 citations. Previous affiliations of Ritu Banerjee include Vanderbilt University Medical Center & Monroe Carell Jr. Children's Hospital at Vanderbilt.
Papers
More filters
Journal ArticleDOI
Randomized Trial of Rapid Multiplex Polymerase Chain Reaction–Based Blood Culture Identification and Susceptibility Testing
Ritu Banerjee,Christine B Teng,Scott A. Cunningham,Sherry M. Ihde,James M. Steckelberg,James P. Moriarty,Nilay Shah,Jayawant N. Mandrekar,Robin Patel +8 more
TL;DR: A prospective randomized controlled trial evaluating outcomes associated with rapid multiplex PCR detection of bacteria, fungi, and resistance genes directly from positive BCBs found that rmPCR reported with templated comments reduced treatment of contaminants and use of broad-spectrum antimicrobials.
Journal ArticleDOI
A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
Ritu Banerjee,James R. Johnson +1 more
TL;DR: In this article, the authors discuss the epidemiology and molecular phylogeny of Escherichia coli sequence type 131 (ST131) and its key subclones, possible mechanisms for their ecological success, implications of their widespread dissemination, and future research needs.
Journal ArticleDOI
Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.
Ritu Banerjee,Brian D. Johnston,Christine M. Lohse,Stephen B. Porter,Connie Clabots,James R. Johnson +5 more
TL;DR: ST131 is a dominant, antimicrobial-resistant clonal group associated with healthcare settings, elderly hosts, and persistent or recurrent symptoms.
Journal ArticleDOI
Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
Ritu Banerjee,Ari Robicsek,Michael A. Kuskowski,Stephen B. Porter,Brian D. Johnston,Evgeni V. Sokurenko,Veronika Tchesnokova,Lance B. Price,Lance B. Price,James R. Johnson +9 more
TL;DR: Although both subclones were associated with ESBL production, H30-Rx isolates had higher resistance scores and were associated specifically with CTX-M-15, and three virulence genes were more prevalent among H30 than non-H30 ST131 isolates.
Journal ArticleDOI
A mecA-Negative Strain of Methicillin-Resistant Staphylococcus aureus with High-Level β-Lactam Resistance Contains Mutations in Three Genes
TL;DR: Genome resequencing of a ceftobiprole-resistant Staphylococcusaureus strain, CRB, revealed that it differs from its parent by five single-nucleotide polymorphisms in three genes, specifically, those encoding PBP4, a low-molecular-weight penicillin-binding protein, GdpP, a predicted signaling protein, and AcrB, a cation multidrug efflux transporter.